ISM (Intisari Sains Medis) : Jurnal Kedokteran
Vol. 13 No. 1 (2022): (Available Online : 1 April 2022)

Relationship between Monocarboxylate Transporter 4 (MCT-4) Expression and Breast Cancer Clinicopathology and Subtype in Sanglah General Hospital, Denpasar, Indonesia

Gede Andry Nicolas Andry Nicolas (Surgery Residency Program, Udayana University Faculty of Medicine,Sanglah Central Public Hospital, Denpasar, Indonesia,)
I Wayan Sudarsa (Department of Oncological Surgery, Department of Surgery, Udayana University Faculty of Medicine, Sanglah Central Public Hospital, Denpasar, Indonesia,)
Putu Anda Tusta Adiputra (Department of Oncological Surgery, Department of Surgery, Udayana University Faculty of Medicine, Sanglah Central Public Hospital, Denpasar, Indonesia)
Desak Made Wihandani (Biochemistry Department, Faculty of Medicine, Udayana University, Indonesia)
I Gede Putu Supadmanaba (Biochemistry Department, Faculty of Medicine, Udayana University, Indonesia)



Article Info

Publish Date
07 Feb 2022

Abstract

Background: Breast cancer is the second leading cause of death in women in developing countries. The activity of Warburg and Reverse-Warburg effects on breast cancer is reflected by the expression patterns of two molecules, namely caveolin-1 and Monocarboxylate Transporter-4 (MCT-4). MCT-4 is a transmembrane transport protein that transports lactate from the cytoplasm to the intercellular fluid.Method: This is a cross-sectional analytical study to determine the relationship between MCT-4 expression and breast cancer clinicopathology and subtypes. The study was conducted between April and May of 2020 with 62  breast cancer patients as samples in Sanglah General Hospital, Denpasar. Analysis was done with SPSS 25.Results: A logistic regression analysis was performed to analyze the relationship between the dependent variable (MCT-4) and the covariates (stage, grade, and subtype). Of the three variables significantly associated with MCT-4 expression, only clinical-stage and subtype (luminal and non-luminal) remained independently associated with MCT-4 expression. Analysis on the clinical stage and subtype variables showed an adjusted OR of 4.727 (p = 0.047; 95% CI: 1.109 - 21.922) and 17.850 (p = 0.009; 95% CI: 2.069 - 154.003) , respectively. This suggests that MCT-4 has a significant association with subtype and clinical-stage, increasing the risk of cancer stage progression and developing a more malignant (non-luminal) subtype.Conclusion: High MCT-4 expression was significantly associated with malignant subtypes, high histological-grade cancer and advanced breast cancer.

Copyrights © 2022






Journal Info

Abbrev

ism

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology

Description

Intisari Sains Medis is published by Medical Scientific Community, Indonesia. Intisari Sains Medis is an international, multidisciplinary, peer-reviewed, open access journal accepts papers for publication in all aspects of Science Digest, Medical Research Development, Research Medical Field and ...